Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|January 22, 2009
Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylationCrystal M Cordes, Robert G Bennett, Gerri L Siford, et al.
Biology|October 27, 2023
Reduction in Obesity-Related Hepatic Fibrosis by SR1664Benita L McVicker, Ronda L Simpson, Frederick G Hamel, et al.
World Journal of Hepatology|February 9, 2016
Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liverSizhao Lu, Robert G Bennett, Kusum K Kharbanda, et al.
Molecular and Cellular Endocrinology|January 21, 2019
Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathwaysHooi Hooi Ng, Matthew Shen, Chrishan S Samuel, et al.
Annals of the New York Academy of Sciences|June 16, 2005
Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissueRobert G Bennett, Katrina J Mahan, Martha J Gentry-Nielsen, et al.
Hepatology Communications|March 27, 2023
Alcohol-induced tubulin post-translational modifications directly alter hepatic protein traffickingRaghabendra Adhikari, Ramyajit Mitra, Robert G Bennett, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2013
Relaxin decreases the severity of established hepatic fibrosis in miceRobert G Bennett, Dean G Heimann, Sudhir Singh, et al.
Biochemical and Biophysical Research Communications|May 19, 2004
Biological activity of a fragment of insulinWilliam C Duckworth, Janet Fawcett, Brian T Tsui, et al.
Transplantation|December 20, 2012
Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in ratsVijay Shivaswamy, Robert G Bennett, Cara C Clure, et al.
Molecular and Cellular Endocrinology|February 18, 2019
Relaxin and fibrosis: Emerging targets, challenges, and future directionsAnthony J Kanai, Elisa M Konieczko, Robert G Bennett, et al.
Pageof 5